1. Home
  2. IROQ vs ACRV Comparison

IROQ vs ACRV Comparison

Compare IROQ & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IROQ
    SELLHOLDBUYas of 18 hours ago
  • ACRV
    SELLHOLDBUYas of 18 hours ago
  • Stock Information
  • Founded
  • IROQ 1883
  • ACRV 2018
  • Country
  • IROQ United States
  • ACRV United States
  • Employees
  • IROQ N/A
  • ACRV N/A
  • Industry
  • IROQ Savings Institutions
  • ACRV Medicinal Chemicals and Botanical Products
  • Sector
  • IROQ Finance
  • ACRV Health Care
  • Exchange
  • IROQ Nasdaq
  • ACRV Nasdaq
  • Market Cap
  • IROQ 78.9M
  • ACRV 73.5M
  • IPO Year
  • IROQ 2011
  • ACRV 2022
  • Fundamental
  • Price
  • IROQ $24.09
  • ACRV $2.03
  • Analyst Decision
  • IROQ
  • ACRV Strong Buy
  • Analyst Count
  • IROQ 0
  • ACRV 6
  • Target Price
  • IROQ N/A
  • ACRV $21.80
  • AVG Volume (30 Days)
  • IROQ 3.7K
  • ACRV 170.2K
  • Earning Date
  • IROQ 04-29-2025
  • ACRV 05-13-2025
  • Dividend Yield
  • IROQ 1.72%
  • ACRV N/A
  • EPS Growth
  • IROQ 56.77
  • ACRV N/A
  • EPS
  • IROQ 0.95
  • ACRV N/A
  • Revenue
  • IROQ $24,226,000.00
  • ACRV N/A
  • Revenue This Year
  • IROQ N/A
  • ACRV N/A
  • Revenue Next Year
  • IROQ N/A
  • ACRV N/A
  • P/E Ratio
  • IROQ $24.30
  • ACRV N/A
  • Revenue Growth
  • IROQ 8.37
  • ACRV N/A
  • 52 Week Low
  • IROQ $14.85
  • ACRV $2.02
  • 52 Week High
  • IROQ $25.76
  • ACRV $11.90
  • Technical
  • Relative Strength Index (RSI)
  • IROQ 51.44
  • ACRV 21.46
  • Support Level
  • IROQ $23.07
  • ACRV $5.00
  • Resistance Level
  • IROQ $24.90
  • ACRV $5.65
  • Average True Range (ATR)
  • IROQ 0.65
  • ACRV 0.44
  • MACD
  • IROQ -0.08
  • ACRV -0.37
  • Stochastic Oscillator
  • IROQ 37.92
  • ACRV 0.28

Stock Price Comparison Chart: IROQ vs ACRV

IROQ
ACRV
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250246810121416182022242628IROQ VS ACRV

About IROQ IF Bancorp Inc.

IF Bancorp Inc is a holding company. It is mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company with the association take deposits from the general public and invest those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, others and also a variety of deposit accounts and alternative delivery channels.

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use